輸入代號或公司名稱後按 Enter
1565

精華

-1.10 (-1.12%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
97.1077成交張數12.09本益比0.76股價淨值比5.97%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q21.61182.5%8.030.819.2%1.27%6.38%
2026Q11.39-59.5%6.990.707.8%1.09%5.60%
2025Q42.34-47.9%9.031.1812.5%1.82%6.94%
2025Q32.69-31.0%11.181.3513.5%2.13%8.86%
2025Q20.57-78.6%12.390.292.7%0.46%10.08%
2025Q13.43-9.0%14.481.7315.6%2.70%11.95%
2024Q44.49110.8%14.822.2618.4%3.52%11.77%
2024Q33.9042.9%12.461.9616.1%3.16%10.18%
2024Q22.66-2.9%11.291.3413.5%2.23%9.49%
2024Q13.7716.7%11.371.9017.3%3.14%9.77%
2023Q42.13-39.8%10.831.079.4%1.76%8.80%
2023Q32.73-54.4%12.241.3813.1%2.31%10.21%
2023Q22.74-42.9%15.501.3812.8%2.37%13.42%
2023Q13.23-45.1%17.561.6314.4%2.71%15.72%
2022Q43.54-21.3%20.211.7915.6%2.90%16.65%
2022Q35.996.6%21.173.0223.5%5.10%18.07%
2022Q24.8014.8%20.802.4219.7%4.29%17.74%
2022Q15.8830.7%20.182.9722.0%5.16%17.91%
2021Q44.50-1.8%18.802.2717.1%3.87%16.34%
2021Q35.62135.2%18.882.8319.9%4.80%17.14%
2021Q24.1849.3%15.652.1115.7%3.54%13.95%
2021Q14.50-10.2%14.272.2717.4%3.95%12.12%
2020Q44.58-25.7%14.782.3116.6%4.20%13.08%
2020Q32.39-56.5%16.361.2011.3%2.27%15.26%
2020Q22.80-54.8%19.471.4211.6%2.51%18.85%
2020Q15.01-34.8%22.862.5218.9%4.29%18.88%
2019Q46.16-26.0%25.533.1119.7%5.54%22.25%
2019Q35.50-33.5%27.692.7717.6%5.23%25.79%
2019Q26.19-34.7%30.463.1219.8%5.49%30.30%
2019Q17.689.7%33.753.8723.8%6.45%28.51%
2018Q48.326.1%33.074.2024.6%7.50%29.78%
2018Q38.27-16.1%32.594.1725.1%8.06%31.65%
2018Q29.485.5%34.184.7827.8%8.93%36.38%
2018Q17.0044.9%33.693.5322.3%6.34%30.44%
2017Q47.84-18.3%31.523.9624.1%7.61%30.07%
2017Q39.8611.7%33.284.9728.0%10.44%34.58%
2017Q28.993.1%32.254.5329.2%9.14%37.11%
2017Q14.83-40.4%31.982.4416.8%4.60%30.97%
2016Q49.6035.264.8428.8%9.80%
2016Q38.834.4525.9%9.94%